[HTML] springer.comFull View

[HTML][HTML] Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus …

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - Drugs in R & D, 2011 - Springer
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …
被引用次数：109 相关文章

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive.

C Klipping, I Duijkers, S Parke, U Mellinger… - Drugs in …, 2011 - search.ebscohost.com
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol …

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - 2011 - pubmed.ncbi.nlm.nih.gov
Background A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …
[PDF] researchgate.net

[PDF][PDF] Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - researchgate.net
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol …

C Klipping, I Duijkers, S Parke, U Mellinger… - Drugs in R&D, 2011 - europepmc.org
Background A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

C Klipping, I Duijkers, S Parke… - Drugs in R & D …, 2011 - search.proquest.com
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol …

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - Drugs in R&D, 2011 - go.gale.com
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …
[HTML] nih.gov

[HTML][HTML] Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus …

C Klipping, I Duijkers, S Parke, U Mellinger… - Drugs in R&D, 2011 - ncbi.nlm.nih.gov
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …
[PDF] psu.edu

[PDF][PDF] Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - Citeseer
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

C Klipping, I Duijkers, S Parke, U Mellinger, M Serrani… - Drugs in R&D, 2011 - infona.pl
Background: A novel estradiol-based combined oral contraceptive (COC) is currently
available in many countries worldwide, including Europe and the US. Based on previous …